|
Folders
|
| Support for businesses |
-- |
-- |
2 Years Ago |
2 Years Ago |
|
| Independent High Risk AGP Panel |
-- |
-- |
1 Year Ago |
1 Year Ago |
|
| Daily contact testing (DCT) |
-- |
-- |
4 Months Ago |
3 Months Ago |
|
| New COVID-19 variants |
-- |
-- |
1 Year Ago |
7 Months Ago |
|
|
Documents
|
| SARS-CoV-2 variant under investigation, meeting minutes |
91KB |
Approved |
1 Year Ago |
1 Year Ago |
|
| New SARS-COV-2 variant - information and risk assessment |
2.1MB |
Approved |
1 Year Ago |
1 Year Ago |
|
| COVID-19 outbreaks following full reopening of primary and secondary schools in England retrospective, cross-sectional national surveillance |
833KB |
Approved |
1 Year Ago |
1 Year Ago |
|
| SARS-CoV-2 infections in children following the re-opening of schools and the impact of national lockdown during Autumn 2020 prospective, national observational cohort surveillance, England |
1.6MB |
Approved |
1 Year Ago |
1 Year Ago |
|
| Power BI tool overview |
25.9MB |
Approved |
1 Year Ago |
1 Year Ago |
|
| Mitigation of risks of COVID-19 in occupational settings with a focus on ethnic minority groups |
269KB |
Approved |
1 Year Ago |
1 Year Ago |
|
| Public health impact of mass sporting and cultural events in a rising COVID-19 prevalence in England |
465KB |
Approved |
11 Months Ago |
11 Months Ago |
|
| MMR, MenACWY and COVID-19 University communications toolkit |
1.2MB |
Approved |
11 Months Ago |
11 Months Ago |
|
| Vaccine effectiveness and duration of protection of covid vaccines against mild and severe COVID-19 in the UK |
1.2MB |
Approved |
10 Months Ago |
10 Months Ago |
|
| COVID-19 vaccination programme core training slide set v14 |
9.9MB |
Approved |
10 Months Ago |
10 Months Ago |
|
| Letter of invitation for Respiratory Evidence Panel - individual and group |
144KB |
Approved |
9 Months Ago |
9 Months Ago |
|
| COVID-19 Vaccination programme core training slide set |
11.6MB |
Approved |
8 Months Ago |
8 Months Ago |
|
| Booster effectiveness |
721KB |
Approved |
7 Months Ago |
7 Months Ago |
|
| Effectiveness of BNT162b2 COVID-19 booster vaccine |
527KB |
Approved |
7 Months Ago |
7 Months Ago |
|
| Confirmed_Omicron_cases_LTLA_2021-12-23.csv |
5KB |
Approved |
7 Months Ago |
7 Months Ago |
|
| Effectiveness of 3 doses of COVID-19 vaccines against symptomatic COVID-19 and hospitalisation in adults aged 65 years and older |
150KB |
Approved |
7 Months Ago |
7 Months Ago |
|
|
|
|
|
|
|